RxDoctor Payments Data

Charlene Rohm

Interventional Cardiology · Augusta, GANPI 1922462241

Payments from drug & device makers

What this record shows

This record is dominated by grants: $54,000 of the $67,369 with a category attached, or 80.2%. Abbott accounts for 83.3% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2024 at $61,811 and has fallen 94.5% since, to $3,387 in 2025.

$67,369in general payments, 2019–2025

Across 140 payments — averaging $481.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$56K
  • Edwards Lifesciences$5K
  • Medtronic$2K
  • Boston Scientific$1K
  • Terumo Medical Corporation$1K
  • Penumbra, Inc.$680
  • plus $1K from 11 others

What the payments were for

  • Grants$54,00080%
  • Travel & lodging$5,7429%
  • Food & beverage$7,25011%
  • Education$3771%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$67,369 in reported general payments places this provider in the 85th percentile of 218 interventional cardiology providers in Georgia.

See all interventional cardiology providers in Georgia

Other interventional cardiology in Augusta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →